1-2 of 2
Johann Lanng Nielsen
Close
Sort by
Journal Articles

Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

Michele Baccarani, Fausto Castagnetti, Bengt Simonsson, Kimmo Porkka, Ibrahim C. Haznedaroglu, Arnon Nagler, Francesca Palandri, Giovanna Rege Cambrin, Luciano Levato, Fausto Palmieri, Elisabetta Abruzzese, Ugur Özbek, Veli Kairisto, Hans Bostrom, Johann Lanng Nielsen, Henrik Hjorth-Hansen, Ole Weis-Bjerrum, Nicoletta Testoni, Giovanni Martinelli, Fabrizio Pane, MD, Giuseppe Saglio, Gianantonio Rosti
Journal: Blood
Blood (2008) 112 (11): 185.
https://doi.org/10.1182/blood.V112.11.185.185
Published: 2008
Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Hans Boström, MD, PhD, Tuija Lundan, M.Sc., Morten Tolstrup Andersen, M.Sc., Gisela Barbany, MD, Ph.D, Thoas Fioretos, MD, Ph.D, Irina Golovleva, Ph.D, Jon Jonasson, MD, Ph.D, Vesa Juvonen, Ph.D, Mikael Lindlöf, Ph.D, Mats Irgen Olsen, MD, Niels Pallisgaard, Ph.D, Eeva-Riitta Savolainen, MD, Ph.D, Marie Schaffer, MD, Ph.D, Aleksandra Silye, Henrik Hjorth-Hansen, MD, Ph.D, Magnus K. Magnusson, MD, Ph.D, Johann Lanng Nielsen, MD, Ph.D, Kimmo Porkka, MD, Ph.D, Bengt Simonsson, MD, Ph.D, Veli Kairisto, MD
Journal: Blood
Blood (2007) 110 (11): 4559.
https://doi.org/10.1182/blood.V110.11.4559.4559
Published: 2007